These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 1794739)
1. Parenchymal brain leukemia. Case report: problems related to the diagnosis and treatment. Corbetta A; Jankovic M; Conter V; Fuga T; Crivellaro M; Masera G Haematologica; 1991; 76(4):324-6. PubMed ID: 1794739 [TBL] [Abstract][Full Text] [Related]
2. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan. Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507 [TBL] [Abstract][Full Text] [Related]
3. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG). van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546 [TBL] [Abstract][Full Text] [Related]
5. High-dose cytosine arabinoside and fractionated total body irradiation as a preparative regimen for the treatment of children with acute lymphoblastic leukemia and Down syndrome by allogeneic bone marrow transplantation. Conter V; D'Angelo P; Rizzari C; Jankovic M; Dampier C; Masera G; Johnson FL Bone Marrow Transplant; 1996 Feb; 17(2):287-9. PubMed ID: 8640182 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center]. Doubek M; Mayer J; Korístek Z; Protivánková M; Brychtová Y; Oborilová A; Král Z; Klabusay M; Tomíska M; Buchtová I; Vorlícek J Cas Lek Cesk; 2002 Mar; 141(4):122-6. PubMed ID: 12046256 [TBL] [Abstract][Full Text] [Related]
8. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission. Singhal S; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Mehta J Bone Marrow Transplant; 1996 Apr; 17(4):637-41. PubMed ID: 8722368 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994 [TBL] [Abstract][Full Text] [Related]
10. [Clinical trial of protocol-AL851 for children with high-risk acute lymphoblastic leukemia. Kyushu Yamaguchi Children's Cancer Study Group (KYCCSG)]. Matsuzaki A; Ishii E; Ueda K; Yanai F; Nibu K; Take H; Koga H; Miyazaki S; Inoue T; Miyake K Rinsho Ketsueki; 1994 Sep; 35(9):862-70. PubMed ID: 7967055 [TBL] [Abstract][Full Text] [Related]
11. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature. Dunphy CH; Kitchen S; Saravia O; Velasquez WS Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944 [TBL] [Abstract][Full Text] [Related]
12. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group]. Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409 [TBL] [Abstract][Full Text] [Related]
13. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E; Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744 [TBL] [Abstract][Full Text] [Related]
14. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis. Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E; Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036 [TBL] [Abstract][Full Text] [Related]
15. [Superior sagittal sinus thrombosis during remission induction therapy for acute lymphoblastic leukemia]. Yoshimi A; Taoka K; Nakasone H; Iijima K; Kida M; Iki S; Urabe A; Usuki K Rinsho Ketsueki; 2006 Dec; 47(12):1533-8. PubMed ID: 17233472 [TBL] [Abstract][Full Text] [Related]
16. [Long-term follow-up of 2 therapeutic programs for the treatment of high-risk childhood acute lymphoblastic leukemia. Experience at the 20 de Noviembre National Medical Center]. de Diego-Floreschapa J; López-Hernández M; Borbolla-Escoboza JR; Trueba-Christy E; Carrillo-Rosales T; González-Avante M Gac Med Mex; 1999; 135(3):253-8. PubMed ID: 10425822 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease. Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87. Einsiedel HG; von Stackelberg A; Hartmann R; Fengler R; Schrappe M; Janka-Schaub G; Mann G; Hählen K; Göbel U; Klingebiel T; Ludwig WD; Henze G J Clin Oncol; 2005 Nov; 23(31):7942-50. PubMed ID: 16258094 [TBL] [Abstract][Full Text] [Related]
19. Effective prevention of central nervous system leukemia with intrathecal methotrexate and intrathecal methotrexate, cytosine arabinoside, and hydrocortisone in childhood acute lymphocytic leukemia. Aur RJ; Hanna M; Sabbah R; Sackey K; Willoughby S; Atwood J Haematol Blood Transfus; 1990; 33():504-10. PubMed ID: 2323651 [No Abstract] [Full Text] [Related]